Ulrich Beyendorff, L.Ac., Dipl.C.H.

Alternative Medicine

Additional Information

Ulrich Beyendorff is a licensed acupuncturist (L.Ac.) and Diplomate of Chinese Herbal Medicine (Dipl.C.H.). He is the senior acupuncturist at the HFA Alternative Medicine Clinic.

Uli completed his studies at the San Francisco College of Acupuncture and Oriental Medicine in 1989 and he is a graduate of the Academy of Traditional Chinese Medicine, Xi Yuan Hospital, Beijing. His studies there included a focus on herbal medicine, gastroenterology, gynecology and internal medicine. He continued his studies in 1992 at the Cheng du College of Traditional Chinese Medicine with a focus on acupuncture, orthopedics and traumatology, hepatology, eye diseases and dermatology.

In China, Uli received extensive training in Chinese herbal medicine. He has lectured on Asian herbal medicine besides keeping abreast of the European research trends in phytotherapy. He was the first acupuncturist in the U.S. to receive FDA IND approval and NIH funding for a study involving a Chinese combination herbal remedy in the treatment of Hepatitis C, which was published in the Archives of Internal Medicine in 2004.

In 1991 Uli worked as a staff acupuncturist in the Dade County Court System, providing drug detoxification in the countys first drug court model in Miami. He also taught at oriental medicine schools in Florida and Minnesota.

For his recent work as an acupuncturist, Uli has taken advanced training in orthopedic and biomedical acupuncture, completing in 2006 the Biomedical Acupuncture Institute Course for Pain Management. He continues to work with patients in focal areas involving electroacupuncture, neuropathies, soft tissue injuries, orthopedic applications and digestive disorders. He gives lectures on the effects of acupuncture and continues to guide patients in applying herbal medicines for treatment and prevention of chronic conditions.

Additional Resources

http://archinte.ama-assn.org/cgi/content/abstract/164/12/1341

This online article is from the Archives of Internal Medicine discussing a randomized trial of Chinese Herbal Medicines for the treatment of Symptomatic Hepatitis C.